Both ALDH1A1 and ALDH1A3 were associated with positive HER2 status where 26% of tumours positive for either marker were HER2 positive and 11% of negative cases were HER2 positive (P < 0.0001). This evidence concerns the gene ALDH1A3 and neoplasm.